| 28-Jan-2015 | S | Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on January 28, 2015, inter alia, has approved sub-division of nominal value of equity shares of the Company from Rs. 5/- each to nominal value of Rs. 2/- each and consequential amendment to the Memorandum of Association and Articles of Association, subject to approval of Members of the Company to be taken by postal ballot.
Ajanta Pharma Ltd has informed BSE regarding a Press Release dated January 28, 2015, titled 'Ajanta Pharma Board Approves Sub Division of Shares'.
SUB. :- Sub Division of equity shares of Ajanta Pharma Limited. (Scrip Code 532331)
Trading Members of the Exchange are hereby informed that Ajanta Pharma Limited has fixed the Record Date for the purpose of sub division of equity shares of the company.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Ajanta Pharma Limited
(532331)
RECORD DATE
23/03/2015
PURPOSE
Sub Division of existing equity shares of Rs.5/- each into equity shares of Rs.2/- each.
SUB-DIVIDED PAID-UP VALUE
Rs.2/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
20/03/2015 DR-239/2014-2015
Note:-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Rs. 2/- paid up w.e.f. 20/03/2015.
ii. ISIN No. INE031B01031 of Rs.5/- paid up will not be valid for transactions done on the Exchange on or after 20/03/2015.
iii. The new ISIN Number for Rs.2/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 12.03.2015) | 23-Mar-2015 | |
| 26-Apr-2012 | S | Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 26, 2012 have approved sub-division of nominal value of equity shares of the Company from Rs. 10/- each to nominal value of Rs. 5/- each, subject to approval of Members at the ensuing Annual General Meeting (AGM) of the Company.
Ajanta Pharma Limited has informed the Exchange that the shareholders of the Company at their Annual General Meeting had approved splitting of shares from a face-value of Rs.10/- each into two shares of a face-value of Rs. 5/- each. The Board of Directors has fixed the record date for the said corporate action as August 10,2012.
(As Per NSE Bulletin Dated on 19.07.2012)
SUB. :- Sub Division of equity shares of Ajanta Pharma Limited (Scrip Code 532331)
Trading Members of the Exchange are hereby informed that, Ajanta Pharma Limited has fixed the Record Date for the purpose of sub division of equity shares of the company.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Ajanta Pharma Limited
(532331)
RECORD DATE
10.08.2012
PURPOSE
Sub Division of existing equity shares from every ONE equity share of Rs.10/- each into TWO equity shares of Rs.5/- each.
SUB-DIVIDED PAID-UP VALUE
Rs.5/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
09/08/2012 DR-094/2012- 2013
Note:-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Rs. 5/- paid up w.e.f. 09/08/2012.
ii. ISIN No. INE 031B01015 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 09/08/2012.
iii. The new ISIN Number for Rs.5/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 23.07.2012) | 10-Aug-2012 | |
| 28-Oct-2024 | D | We hereby inform that the Board at the Board meeting held on Monday, 28th October 2024, has inter-alia approved the Unaudited (Consolidated & Standalone) Financial Results of the Company for the quarter and half year ended 30.09.2024 and declared 1st interim dividend for FY 2025. PFA enclosed outcome of Board Meeting for more details. | 06-Nov-2024 | |
| 31-Jan-2024 | D | The Board in its meeting held today has approved 2nd Interim Dividend. For more details please find enclosed herewith outcome of the Board Meeting. | 08-Feb-2024 | |
| 28-Jul-2023 | D | Board approved:-
1. First Interim dividend of Rs. 315 cr. for the year FY 2024. It translates into Rs. 25 per share (1250%) on face value ofRs. 2/- per share. This total dividend ofRs. 25 per share includes a regular dividend ofRs. l0 per share, and an additional Rs. 15 per share, distributed as a special dividend on the commemoration of 50 years of momentous joumey of the Company. | 04-Aug-2023 | |
| 28-Jul-2023 | D | Board approved:-
1. First Interim dividend of Rs. 315 cr. for the year FY 2024. It translates into Rs. 25 per share (1250%) on face value ofRs. 2/- per share. This total dividend ofRs. 25 per share includes a regular dividend ofRs. l0 per share, and an additional Rs. 15 per share, distributed as a special dividend on the commemoration of 50 years of momentous joumey of the Company. | 04-Aug-2023 | |
| 03-Nov-2022 | D | Payment of interim dividend of Rs. 7/- (350%) per equity share on the face-value of Rs. 2/-
per share for the Financial Year 2022-23. | 11-Nov-2022 | |
| 29-Oct-2021 | D | Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 29, 2021, inter alia, has approved the following:
- Payment of interim dividend of Rs. 9.50/- (475%) per equity share on the face-value of Rs. 2/- per share for the Financial Year 2021-22.
lnterim dividend will be paid on or after November 16, 2021. | 09-Nov-2021 | |
| 03-Nov-2020 | D | Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 03, 2020, inter alia, have declared interim dividend of Rs. 9.50/- per equity share of face value of Rs. 2/- each for the financial year 2020-21. | 12-Nov-2020 | |
| 05-Nov-2019 | D | Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at their meeting held on November 05, 2019, inter alia, have approved payment of interim dividend of Rs. 13/- (650%) per equity share on the face-value of Rs. 2/- per share for the Financial Year 2019-20:
Further, lnterim dividend will be paid on or after November 20, 2019. | 15-Nov-2019 | |
| 31-Oct-2018 | D | Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 31, 2018, inter alia, has approved payment of interim dividend of Rs. 9/- (450%) per equity share on the face-value of Rs. 2/- per share for the Financial Year 2018-19. | 09-Nov-2018 | |
| 18-Mar-2017 | D | Payment of second interim dividend of Rs. 7/- (350%) per equity share on the face-value of Rs. 2/- per share for the Financial Year 2016-17 and ratified Saturday, 25th March, 2017 as the Record date for payment of interim dividend. The second interim dividend shall be paid to shareholders on or after 27th March, 2017. | 23-Mar-2017 | |
| 26-Oct-2016 | D | Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 26, 2016, inter alia, approved the following:
- Payment of interim dividend of Rs. 6/- (300%) per equity share on the face-value of Rs. 2/- per share for the Financial Year 2016-17. | 07-Nov-2016 | |
| 09-Mar-2016 | D | Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 09, 2016, inter alia, has declared an interim dividend of Rs. 8/- (400%) per equity share on the face value of Rs. 2/- per share for the Financial Year 2015-16.
The Board Meeting commenced at 11.00 a.m. and concluded at 11.30 a.m.
Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 29, 2016, inter alia, transacted the following :
- Board has recommended that interim dividend declared at the meeting held on March 09, 2016, be considered as final dividend on the equity shares of the Company for the financial year ended March 31, 2016.
(As Per BSE Announcement Dated on 28.04.2016)
| 17-Mar-2016 | |
| 08-May-2015 | D | Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 08, 2015, inter alia, have recommended dividend @ Rs. 6/- per equity share on the face value of Rs. 2/- each, subject to approval of shareholders at the ensuing Annual General Meeting to be held in 2015. | 25-Jun-2015 | |
| 05-May-2014 | D | Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 05, 2014, inter alia, have recommended dividend @ Rs. 10/- per equity share on the face value of Rs. 5/- each, subject to approval of shareholders at the ensuing Annual General Meeting to be held in 2014. | 24-Jul-2014 | |
| 30-Apr-2013 | D | Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 30, 2013, inter alia, have recommended Dividend @ Rs. 6.25 per equity share of the face value of Rs. 5/- each, subject to approval of Shareholders at the ensuing Annual General Meeting to be held on July 13, 2013. | 18-Jul-2013 | |
| 26-Apr-2012 | D | Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 26, 2012, inter alia, have recommended dividend @ Rs. 7.50 per equity share of the face value of Rs. 10/- each, subject to approval of shareholders at the ensuing Annual General Meeting to be held on July 07, 2012. | 28-Jun-2012 | |
| 30-Apr-2011 | D | Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 30, 2011, inter alia, have recommended the dividend @ Rs. 5/- per share, subject to the approval of the shareholders at the ensuing Annual General Meeting to be held on July 08, 2011. | 23-Jun-2011 | |
| 06-May-2010 | D | Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 06, 2010, inter alia, has recommended the dividend @ Rs. 3.50 per equity share, subject to the approval of the shareholders at the ensuing Annual General Meeting to be held on July 09, 2010. | 29-Jun-2010 | |
| 15-May-2009 | D | Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 15, 2009, inter alia, has recommended the Dividend @ Rs 2.50 per share, subject to the approval of the shareholders at the ensuing Annual General Meeting to be held on July 09, 2009. | 30-Jun-2009 | |
| 30-Apr-2008 | D | Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 30, 2008, inter alia, has recommended the dividend @ Rs 2.50 per share for the year ended March 31, 2008, subject to the approval of the shareholders at the ensuing Annual General Meeting to be held on June 27, 2008. | 27-Jun-2008 | |
| 27-Apr-2007 | D | Ajanta Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 27, 2007, inter alia, has recommended the dividend @ Rs 2.00 per share, subject to the approval of the shareholders at the ensuing Annual General Meeting to be held on September 28, 2007. | 19-Sep-2007 | |
| 13-Jun-2022 | B | 1:2 Bonus Issue of Equity Shares
Trading Members of the Exchange are hereby informed that, Ajanta Pharma Ltd. has fixed the Record Date for the purpose of Bonus Issue. The transactions in the equity shares of the company would be on an ex-bonus basis with effect from the under mentioned date:
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Ajanta Pharma Ltd.
(532331)
RECORD DATE
23.06.2022
PURPOSE
Issue of 1 (One) Bonus equity shares of Rs.2/- each for every 2 (Two) existing equity share of Rs.2/- each held.
Ex-Bonus basis from Date & Sett. No.
22/06/2022 DR- 058/2022-2023
(As Per BSE Notice Dated on 16.06.2022) | 23-Jun-2022 | 1:2 |
| 06-Sep-2013 | B | 1:2 Bonus Issue of Equity Shares
SUB. :- Bonus issue of Ajanta Pharma Ltd.(Scrip Code: 532331)
Trading Members of the Exchange are hereby informed that Ajanta Pharma Ltd. has fixed the Record Date for the purpose of Bonus Issue. The transactions in the equity shares of the Company should be on an ex-bonus basis with effect from the under mentioned date.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
Ajanta Pharma Ltd.
(532331)
RECORD DATE
18.09.2013
PURPOSE
Issue of 1 (ONE) Bonus equity share of Rs. 5/- each for every 2 (TWO) existing equity shares of Rs. 5/- each held.
Ex-Bonus basis from Date & Sett. No
17/09/2013 DR-119/2013-2014
Trading Members of the Exchange are requested to take note of it.
(As Per BSE Notice Dated on 10.09.2013) | 18-Sep-2013 | 1:2 |
| 28-Oct-2024 | BC | We hereby inform that the Board at the Board meeting held on Monday, 28th October 2024, has inter-alia approved the Unaudited (Consolidated & Standalone) Financial Results of the Company for the quar | 31-Mar-2025 | |
| 17-Jan-2025 | BC | AJANTA PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2025 ,inter alia, to consider and approve Unaudited consolidated & standalone financ | 30-Jan-2025 | |
| 27-Dec-2024 | BC | Source:BSE Announcement PDF | 27-Dec-2024 | |
| 27-Dec-2024 | BC | Source: BSE Announcement PDF | 27-Dec-2024 | |
| 27-Dec-2024 | BC | Source:BSE Announcement PDF | 27-Dec-2024 | |